Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients

NCT01796730 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: bambuterol
DRUG: Placebo

Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Collaborators

[object Object]
[object Object]